Showing results (121-130 of 17,194) with videos related to

Sort By:
Pageof 1,720
The Journal of Clinical Investigation|March 1, 1995
Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cellsP Naredi, D D Heath, R E Enns, et al.
Cancer Drug Delivery|January 1, 1985
Maintenance of peritoneal catheter function by the intraperitoneal administration of 32% dextran 70C E Pfeifle, S B Howell, I S Abramson, et al.
Molecular Pharmacology|January 1, 1997
Role of determinants of cadmium sensitivity in the tolerance of Schizosaccharomyces pombe to cisplatinP Perego, J Vande Weghe, D W Ow, et al.
Cancer Research|March 1, 1980
Antitumor activity of L-canavanine against L1210 murine leukemiaM H Green, T L Brooks, J Mendelsohn, et al.
Molecular Pharmacology|November 28, 2000
p53 interacts with the DNA mismatch repair system to modulate the cytotoxicity and mutagenicity of hydrogen peroxideX Lin, K Ramamurthi, M Mishima, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Enhancement of the cytotoxicity of cisplatin by the cholecystokinin antagonist MK-329 in a human pancreatic cancer cell lineR Jamshidipour, E B Pinho, D K Hom, et al.
British Journal of Cancer|January 1, 1996
Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153D P Gately, A Sharma, R D Christen, et al.
Cancer Treatment Reports|June 1, 1986
Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycinM Markman, S Cleary, W Lucas, et al.
Cancer Research|January 1, 1988
cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsP A Andrews, S Velury, S C Mann, et al.
Cancer Research|March 1, 1983
Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protectionS B Howell, C E Pfeifle, W E Wung, et al.
Pageof 1,720